Induced pluripotent stem cells (iPSCs) are adult somatic cells genetically reprogrammed to an embryonic stem cell-like state. Notwithstanding their autologous origin and their potential to differentiate towards cells of all three germ layers, iPSC reprogramming is still affected by low efficiency. As dermal fibroblast is the most used human cell for reprogramming, we hypothesize that the variability in reprogramming is, at least partially, because of the skin fibroblasts used. Human dermal fibroblasts harvested from five different anatomical sites (neck, breast, arm, abdomen and thigh) were cultured and their morphology, proliferation, apoptotic rate, ability to migrate, expression of mesenchymal or epithelial markers, differentiation potential and production of growth factors were evaluated in vitro. Additionally, gene expression analysis was performed by real-time PCR including genes typically expressed by mesenchymal cells. Finally, fibroblasts isolated from different anatomic sites were reprogrammed to iPSCs by integration-free method. Intriguingly, while the morphology of fibroblasts derived from different anatomic sites differed only slightly, other features, known to affect cell reprogramming, varied greatly and in accordance with anatomic site of origin. Accordingly, difference also emerged in fibroblasts readiness to respond to reprogramming and ability to form colonies. Therefore, as fibroblasts derived from different anatomic sites preserve positional memory, it is of great importance to accurately evaluate and select dermal fibroblast population prior to induce reprogramming.
| INTRODUC TI ON
Induced pluripotent stem cells (iPSCs) are adult somatic cells genetically reprogrammed to an embryonic stem cell (ESC)-like state.
Since pioneering works that led to the successful reprogramming of mouse 1 and human 2, 3 fibroblasts, iPSCs have been obtained from somatic cells of several other species. [4] [5] [6] Remarkable similarity of iPSCs to ESC, along with their origin from adult somatic cells, make iPSCs a tremendously valuable tool for regenerative medicine, disease modelling, drug discovery and testing, [7] [8] [9] while avoiding the ethical concerns associated with ESC.
Notwithstanding iPSCs functional resemblance to ESC, their clinical application is still prevented by severe technical problems, mostly related to both reprogramming technology and low efficiency of reprogramming. Although reprogramming technology has been significantly improved by integration-free methods based on episomal vectors, 10 synthetic modified mRNA 11 or direct delivery of reprogramming proteins, 12 efficiency of reprogramming of human cells is still as low as 2% with integration-free methods, and 6.2% at best with integration methods. 13 Several enhancers and barriers of reprogramming have been described thus far. Accordingly, novel strategies to activate enhancers or inhibit barriers are emerging.
14 Recently, reprogramming efficiencies of 80%-100% were achieved by genetic combinatorial modulation of specific signalling pathways. 15 These results shed light on the mechanisms governing cell reprogramming, but do not allow transcending the limitations to iPSC clinical translation. Additionally, evidence supporting variability in efficiency of reprogramming and in properties of iPSCs in accordance with the cell type from which iPSCs were generated was also reported. 16, 17 Adult dermal fibroblast has been the first human cell successfully reprogrammed to iPSCs, 3 and, to date, it is still the most used human cell for re- On this basis, we hypothesize that dermal fibroblasts differ not only in their gene expression profile, but also in other biological characteristics that might be, even partially, responsible for different response to reprogramming technology. To test our hypothesis we compared the morphology, expression of specific markers, production of soluble factors, proneness to apoptosis, proliferation rate, ability to migrate and differentiation potential of adult human dermal fibroblasts isolated from different anatomic sites and analysed any difference occurring among cell populations.
| MATERIAL S AND ME THODS

| Tissue samples
Skin fragments from five different anatomic sites (n = 25, five necks, five breasts, five arms, five abdomens and five thighs) of patients (n = 25, mean age 41.04 ± 7.624, all female patients) undergoing plastic surgery were harvested. Patients provided written, informed consent and specimens were collected, without patient identifiers, following protocols approved by the University Hospital Federico II and in conformity with the principles outlined in the Declaration of Helsinki. 
| Cell culture
| Immunocytochemistry and proliferation index
| Apoptotic index
To determine apoptotic index of fibroblast from all regions, 
| Gene expression profile analysis
Culture dishes(5 × 10 5 cells/60 mm) were plated and cultured for 7 days, then processed for real-time PCR analysis as previously described. 22 Total RNA was extracted in Isol-RNA Lysis Reagent (5Prime, Hamburg, Germany), dissolved in RNase-free water and its final concentration determined at the NanoDrop 1000 spec- 
| Growth factor array
Dermal fibroblasts from all five regions (neck, breast, arm, abdomen and thigh) were plated at medium density ( After further washes, membranes were incubated for 2 hours at room temperature with horseradish peroxidase (HRP)-conjugated streptavidin and washed one last time to remove unbound reagents.
All incubation steps were performed with agitation on orbital shaker.
Membranes were then developed with the detection buffer, exposed 
reprogramming was performed as previously described. 23 Briefly, spot signal densities from the scanned images of arrays were obtained 
| Reprogramming
Dermal fibroblasts from each anatomic site at passage 5 (n = 4) were Medium was, then, replaced and cells were allowed to recover for 6 hours. After the recovery time, cells were transfected and incubated again. Overnight 15-18 hour transfections followed by 6 hour recovery times were repeated for a total of four times, as recommended by manufacturer. Starting from day 5, cells were kept in culture in NutriStem Medium, changing the medium on a daily basis. The formation of colonies was monitored everyday and documented using a phase-contrast microscope (Nikon) equipped with a stage incubator (Okolab). Three independent observers counted the emerging colonies at day 7 and 14 after the last transfection at the phase-contrast microscope (Nikon), while the size of colonies was measured by the NIS Elements software (Nikon). Numbers were then averaged and expressed as mean ± SE.
| Statistical analysis
Data were analysed by GraphPad Prism 5.0 (GraphPad Software, La Jolla, CA), using one-way ANOVA test and Tukey's post test. A value of P ≤ 0.05 identified any statistically significant difference.
| RE SULTS
| Fibroblast morphology in vitro
Outgrowth of fibroblasts occurred after 6-7 days of culture ( Figure 1A ).
Cells adhered to plastic culture dishes, where they spread and, in a time ranging from 14 to 21 days, they reached confluence ( Figure 1B ).
Although most of the cells had spindle-shaped morphology, starshaped fibroblasts were observed in all culture dishes ( Figure 1A ).
| Proliferation and apoptotic indices, ability to migrate
To avoid any effect due to native environment, all primary fibroblasts were cultured under the same condition in vitro for five passages. 
| Expression of mesenchymal and epithelial markers
All fibroblasts in culture were negative for epithelial and endothelial markers like E-cadherin and Factor VIII ( Figure 3) . As for 
| Mesenchymal differentiation and growth factor release
To test the ability to differentiate, human dermal fibroblasts were grown in culture medium supplemented with horse serum or with
Transforming Growth Factor (TGF-β) or with dexamethasone, ascorbic acid and β-glycerophosphate. Even though fibroblasts isolated from all different regions clearly retained the ability to differentiate towards chondrocytes, osteoblasts and adipocytes, as shown by specific histochemical stainings ( Figure 5) , obvious 
F I G U R E 3 Representative images of immunocytochemistry for the in vitro expression of mesenchymal (A-B, D-E, G-H, J-K and M-N) and epithelial (C, F, I, L and O) markers by dermal fibroblasts from neck (A-C), breast (D-F), arm (G-I), abdomen (J-L), and thigh (M-O). Scale bar length is 50 (A-B, D-E, G-H, J-K and M-N) or 100 µm (C, F, I, L and O)
| Reprogramming of dermal fibroblasts
As a proof of concept we reprogrammed dermal fibroblasts using a ready-to-use kit and following the well-established protocol supplied with the reagents. [25] [26] [27] The efficiency of reprogramming, in terms of 
| D ISCUSS I ON
Induced pluripotent stem cells are clearly emerging as the most promising cell type in regenerative medicine, as they are autologous cells characterised by pluripotency comparable to that of ESCs.
Nonetheless, several hurdles related to reproducibility and efficiency of reprogramming are yet to be overcome. Fibroblast was the first adult somatic cell to be successfully reprogrammed and thus far it is still the most used cell for reprogramming. Noteworthily, it has been previously demonstrated that fibroblast are not a homogenous population 28 and that cell origin and characteristics affect cell reprogramming. 17 Despite the common expression of several transcripts of genes typically expressed in mesenchymal cells, 33, 34 there was a heterogeneous expression of CD105 and CD146 when comparing dermal fibroblasts obtained from distinct anatomic sites, with fibroblasts isolated from abdomen skin that had a higher expression of all three markers. Our data are in disagreement with the previous proposal of using CD146 as a marker of mesenchymal stromal/stem cells (MSCs) that is based on the evidence that fibroblasts are CD146-negative. 34, 35 However, heterogeneity of MSCs as well as evidence that MSCs and fibroblasts cannot be unequivocally distinguished in vitro have also been described. 36 Indeed, apart from sharing most of the features and expression of markers of fibroblasts, MSCs, like fibroblasts, exhibit striking variability among tissues of origin and donors that make even more difficult to define a subset of markers to clearly identify them, [37] [38] [39] to such an extent that MSCs isolated from adipose tissue have been described as a CD146-negative cell population. 40, 41 Interestingly though, expression of CD90, CD105 and CD146 by fibroblasts isolated from abdominal skin raise the thorny, and still unaddressed, question of whether fibroblasts and MSCs are not admittedly the same population. 42, 43 Based on our and other F I G U R E 6 Production and release of growth factors by dermal fibroblasts in vitro evaluated by growth factor protein array. A, Representative images of profiles of growth factors released by fibroblasts from different anatomic sites. B. Quantification of selected growth factors. Each value expresses the mean + SE. Culture medium from culture of fibroblasts obtained from three different patients for each site were assayed (n = 3). Asterisks are indicators of the P value as follows: significant (*P ≤ 0.05), very significant (**P ≤ 0.01), and extremely significant (***P ≤ 0.001) vs fibroblasts from abdomen (EGF, GM-CSF, HGF, PDGF-BB and VEGF) or fibroblasts from neck and abdomen (TGF-β2). At the lower right corner layout of protein array and a scheme of anatomic sites of origin of fibroblasts are reported for quick reference. EGF, Epidermal Growth Factor; OD, optical density; HGF, Hepatocyte Growth Factor; VEGF, Vascular Endothelial Growth Factor; GM-CSF, Granulocyte-macrophage colony-stimulating factor; PDGF-BB, Platelet-Derived Growth Factor-BB authors' observations, 33, 34, 41 it is reasonable to consider fibroblasts to be at least an MSC differentiation stage, and to infer that fibro- programming. Therefore, fibroblast reprogramming is more readily and efficiently accomplished from abdominal skin fibroblasts that are facilely and efficiently harvested by a skin punch biopsy that may be performed with a minor unaesthetic scar.
In conclusion, while offering novel perspective on the iPSC reprogramming from dermal fibroblasts, our study also demonstrates that Additionally, while emphasizing fibroblast diversity and the impact of such diversity on cell reprogramming, our study also highlights striking similarity between fibroblasts and MSCs that supports the attracting hypothesis that the most remarkable difference between fibroblasts and MSCs is in the name. [40] [41] [42] [43] 57 
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